A Research Study on The Development of Nanostructured Lipid Carriers for Furosemide Delivery: Formulation and Evaluation
Keywords:
N\AAbstract
Designing and evaluating nanostructured lipid carriers (NLCs) to administer furosemide effectively, a strong loop diuretic with low oral bioavailability because of its substantial first-pass metabolism and low solubility, is the main focus of this study. NLCs were created to increase medication solubility, stability, and simplify controlled release. They are made up of a mixture of liquid and solid lipids stabilized by surfactants. NLCs loaded with furosemide were made via ultrasonography and thermal homogenization. The criteria employed to optimize various formulations included drug entrapment efficiency, zeta potential, particle size, polydispersity index (PDI), and in vitro drug release.
A mean particle size of less than 200 nm was observed in the enhanced NLC formulation, which also had a narrow PDI and a zeta potential that suggested high physical stability. In order to confirm effective drug loading, the entrapment efficiency was noticeably high. The quick release from the pure medication was contrasted with a continuous release profile over a 24-hour period in in vitro release tests. Based on the data, NLCs may be a promising delivery method to increase furosemide's bioavailability and therapeutic effectiveness. It is necessary to conduct additional in vivo research to prove pharmacokinetic benefits
Downloads
Metrics
References
Alam, T., Khan, S., Gaba, B., Haider, M. F., Baboota, S., & Ali, J. (2018). Adaptation of quality by design-based development of isradipine nanostructured–lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate. Journal of pharmaceutical sciences, 107(11), 2914-2926.
Dalal, L., Allaf, A. W., & El-Zein, H. (2021). Formulation and in vitro evaluation of self- nanoemulsifying liquisolid tablets of furosemide. Scientific Reports, 11(1), 1315.
Gul, S., Sridhar, S. B., Jalil, A., Akhlaq, M., Arshad, M. S., Sarwar, H. S., ... & Thomas, S. (2024). Solid Self-Nanoemulsifying Drug Delivery Systems of Furosemide: In Vivo Proof of Concept for Enhanced Predictable Therapeutic Response. Pharmaceuticals, 17(4), 500.
Ahire, E., Thakkar, S., Darshanwad, M., & Misra, M. (2018). Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta pharmaceutica sinica B, 8(5), 733-755.
Fathi, H. A., Yousry, C., Elsabahy, M., El-Badry, M., & El Gazayerly, O. N. (2023). Effective loading of incompatible drugs into nanosized vesicles: A strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings. International Journal of Pharmaceutics, 636, 122852.
Thombre, N. A., Niphade, P. S., Ahire, E. D., & Kshirsagar, S. J. (2022). Formulation development and evaluation of microemulsion based lornoxicam gel. Biosciences Biotechnology Research Asia, 19(1), 69-80.
Zewail, M. B., Asaad, G. F., Swellam, S. M., Abd-Allah, S. M., Hosny, S. K., Sallah, S. K., ... & El-Dakroury, W. A. (2022). Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation. International Journal of Pharmaceutics, 624, 122006.
Natarajan, S. B., Chandran, S. P., Vinukonda, A., & Dharmalingam, S. R. (2019). Green tea catechin loaded nanodelivery systems for the treatment of pandemic diseases. Asian J Pharm Clin Res, 12(5), 1-7.
Duong, V. A., Nguyen, T. T. L., & Maeng, H. J. (2020). Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules, 25(20), 4781.
Poovi, G., & Damodharan, N. (2018). Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs. Future Journal of Pharmaceutical Sciences, 4(2), 191-205.
Gupta, P., Sharma, S., Neupane, Y. R., Khan, Z., Ahmad, S., Emad, N. A. & Sultana, Y. (2023). Co-delivery of exemestane and thymoquinone via nanostructured lipid carriers for efficient breast cancer therapy. Journal of Drug Delivery Science and Technology, 88, 104892.
Nkansah, P., Antipas, A., Lu, Y., Varma, M., Rotter, C., Rago, B., ... & Litchfield, J. (2013). Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. Journal of controlled release, 169(1-2), 150-161.
Li, S.; Wei, N.; Wei, J.; Fang, C.; Feng, T.; Liu, F.; Liu, X.; Wu, B. Curcumin and silver nanoparticles loaded antibacterial multifunctional pectin/gelatin films for food packaging applications. Int. J. Biol. Macromol. 2024, 266, 131248.
Gonçalves, R.F.; Vicente, A.A.; Pinheiro, A.C. Incorporation of curcumin-loaded lipid-based nano delivery systems into food: Release behavior in food simulants and a case study of application in a beverage. Food Chem. 2022, 405, 134740.
Campos, J.R.; Severino, P.; Santini, A.; Silva, A.M.; Shegokar, R.; Souto, S.B.; Souto, E.B. Chapter 1—Solid lipid nanoparticles (SLN): Prediction of toxicity, metabolism, fate and physicochemical properties. In Nanopharmaceuticals; Shegokar, R., Ed.; Elsevier: Amsterdam, The Netherlands, 2020; pp. 1–15.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
